These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16502763)

  • 1. Antidiabetic medications in overdose: a comparison of the inquiries made to a regional poisons unit regarding original sulfonylureas, biguanides and insulin.
    von Mach MA; Gauer M; Meyer S; Omogbehin B; Schinzel H; Kann PH; Weilemann LS
    Int J Clin Pharmacol Ther; 2006 Feb; 44(2):51-6. PubMed ID: 16502763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological assessment of 160 cases of insulin overdose recorded in a regional poisons unit.
    von Mach MA; Meyer S; Omogbehin B; Kann PH; Weilemann LS
    Int J Clin Pharmacol Ther; 2004 May; 42(5):277-80. PubMed ID: 15176650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demographics and outcome of unintentional insulin overdoses managed by three poison centers.
    Beuhler MC; Spiller HA; Aleguas A
    Clin Toxicol (Phila); 2013; 51(8):789-93. PubMed ID: 23964855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of antidiabetic medications in overdose.
    Spiller HA
    Drug Saf; 1998 Nov; 19(5):411-24. PubMed ID: 9825953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of decision tree with common machine learning models for prediction of biguanide and sulfonylurea poisoning in the United States: an analysis of the National Poison Data System.
    Mehrpour O; Saeedi F; Nakhaee S; Tavakkoli Khomeini F; Hadianfar A; Amirabadizadeh A; Hoyte C
    BMC Med Inform Decis Mak; 2023 Apr; 23(1):60. PubMed ID: 37024869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin overdose: A serious iatrogenic complication-Western France Poison Control Centre Data Analysis.
    Stevens A; Hamel JF; Toure A; Hadjadj S; Boels D
    Basic Clin Pharmacol Toxicol; 2019 Nov; 125(5):466-473. PubMed ID: 31215744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides.
    Mannucci E; Monami M; Masotti G; Marchionni N
    Diabetes Metab Res Rev; 2004; 20(1):44-7. PubMed ID: 14737744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral antidiabetic agents: recent aspects].
    Keller U; Berger W
    Schweiz Med Wochenschr; 1983 Apr; 113(17):645-50. PubMed ID: 6191388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features, prevention and management of acute overdose due to antidiabetic drugs.
    Moore DF; Wood DF; Volans GN
    Drug Saf; 1993 Sep; 9(3):218-29. PubMed ID: 8240727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unintentional use of mistaken insulin products: a retrospective review of poison center data.
    Glogan D; Levitan RD; Brooks DE; Gerkin RD
    J Emerg Med; 2013 Oct; 45(4):547-53. PubMed ID: 23684475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemia following inadvertent and factitious sulfonylurea overdosages.
    Klonoff DC; Barrett BJ; Nolte MS; Cohen RM; Wyderski R
    Diabetes Care; 1995 Apr; 18(4):563-7. PubMed ID: 7497872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of severe sideeffects during therapy with sulfonylureas and biguanides.
    Berger W
    Horm Metab Res Suppl; 1985; 15():111-5. PubMed ID: 3865878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non usual cases of hypoglycaemia--hypoglycaemia factitia].
    Mokán M; Galajda P; Mokán M
    Vnitr Lek; 2015 Dec; 61(12 Suppl 5):5S45-9. PubMed ID: 27124972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of sulfonylurea and insulin overdose.
    Klein-Schwartz W; Stassinos GL; Isbister GK
    Br J Clin Pharmacol; 2016 Mar; 81(3):496-504. PubMed ID: 26551662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accidental insulin overdose.
    Batalis NI; Prahlow JA
    J Forensic Sci; 2004 Sep; 49(5):1117-20. PubMed ID: 15461121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five year retrospective evaluation of sulfonylurea ingestion in children.
    Quadrani DA; Spiller HA; Widder P
    J Toxicol Clin Toxicol; 1996; 34(3):267-70. PubMed ID: 8667462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicology of oral antidiabetic medications.
    Spiller HA; Sawyer TS
    Am J Health Syst Pharm; 2006 May; 63(10):929-38. PubMed ID: 16675650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing characteristics of exposure to biguanide and sulfonylurea anti-diabetic medications in the United States.
    Mehrpour O; Saeedi F; Hoyte C; Hadianfar A; Nakhaee S; Brent J
    Am J Emerg Med; 2022 Jun; 56():171-177. PubMed ID: 35398707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide in children with hypoglycaemia due to sulfonylurea ingestion.
    Rath S; Bar-Zeev N; Anderson K; Fahy R; Roseby R
    J Paediatr Child Health; 2008 Jun; 44(6):383-4. PubMed ID: 18476935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide for the treatment of sulfonylurea poisoning.
    Glatstein M; Scolnik D; Bentur Y
    Clin Toxicol (Phila); 2012 Nov; 50(9):795-804. PubMed ID: 23046209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.